| Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 A Afshin, PJ Sur, KA Fay, L Cornaby, G Ferrara, JS Salama, EC Mullany, ... The Lancet 393 (10184), 1958-1972, 2019 | 2351 | 2019 |
| Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic … GBD 2016 Risk Factors Collaborators Lancet (London, England) 390 (10100), 1345, 2017 | 2031 | 2017 |
| Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 CJL Murray, AY Aravkin, P Zheng, C Abbafati, KM Abbas, ... The Lancet 396 (10258), 1223-1249, 2020 | 1392 | 2020 |
| Global, regional and national sodium intakes in 1990 and 2010: a systematic analysis of 24 h urinary sodium excretion and dietary surveys worldwide J Powles, S Fahimi, R Micha, S Khatibzadeh, P Shi, M Ezzati, RE Engell, ... BMJ open 3 (12), e003733, 2013 | 789 | 2013 |
| Effects of dapagliflozin on body weight, total fat mass, and regional adipose tissue distribution in patients with type 2 diabetes mellitus with inadequate glycemic control on … J Bolinder, Ö Ljunggren, J Kullberg, L Johansson, J Wilding, ... The Journal of Clinical Endocrinology & Metabolism 97 (3), 1020-1031, 2012 | 783 | 2012 |
| MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre … J Schwitter, CM Wacker, AC van Rossum, M Lombardi, N Al-Saadi, ... European heart journal 29 (4), 480-489, 2008 | 671 | 2008 |
| Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial SS Anand, J Bosch, JW Eikelboom, SJ Connolly, R Diaz, P Widimsky, ... The Lancet 391 (10117), 219-229, 2018 | 662 | 2018 |
| Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin J Bolinder, Ö Ljunggren, L Johansson, J Wilding, AM Langkilde, ... Diabetes, Obesity and Metabolism 16 (2), 159-169, 2014 | 474 | 2014 |
| MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool H Gad, T Koolmeister, AS Jemth, S Eshtad, SA Jacques, CE Ström, ... Nature 508 (7495), 215-221, 2014 | 450 | 2014 |
| Shifts in fish communities along the productivity gradient of temperate lakes—patterns and the importance of size‐structured interactions L Persson, S Diehl, L Johansson, G Andersson, SF Hamrin Journal of Fish Biology 38 (2), 281-293, 1991 | 440 | 1991 |
| Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial H Bjermo, D Iggman, J Kullberg, I Dahlman, L Johansson, L Persson, ... The American journal of clinical nutrition 95 (5), 1003-1012, 2012 | 434 | 2012 |
| Overfeeding polyunsaturated and saturated fat causes distinct effects on liver and visceral fat accumulation in humans F Rosqvist, D Iggman, J Kullberg, J Cedernaes, HE Johansson, A Larsson, ... Diabetes 63 (7), 2356-2368, 2014 | 327 | 2014 |
| Predator regulation and primary production along the productivity gradient of temperate lake ecosystems L Persson, G Andersson, SF Hamrin, L Johansson Complex interactions in lake communities, 45-65, 1988 | 299 | 1988 |
| Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial SJ Connolly, JW Eikelboom, J Bosch, G Dagenais, L Dyal, F Lanas, ... The Lancet 391 (10117), 205-218, 2018 | 295 | 2018 |
| Relationship between circulating FGF23 and total body atherosclerosis in the community MAI Mirza, T Hansen, L Johansson, H Ahlström, A Larsson, L Lind, ... Nephrology Dialysis Transplantation 24 (10), 3125-3131, 2009 | 272 | 2009 |
| Dapagliflozin has no effect on markers of bone formation and resorption or bone mineral density in patients with inadequately controlled type 2 diabetes mellitus on metformin Ö Ljunggren, J Bolinder, L Johansson, J Wilding, AM Langkilde, ... Diabetes, Obesity and Metabolism 14 (11), 990-999, 2012 | 213 | 2012 |
| The utility of superparamagnetic contrast agents in MRI: theoretical consideration and applications in the cardiovascular system A Bjørnerud, L Johansson NMR in Biomedicine: An International Journal Devoted to the Development and …, 2004 | 213 | 2004 |
| Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study JW Eriksson, P Lundkvist, PA Jansson, L Johansson, M Kvarnström, ... Diabetologia 61 (9), 1923-1934, 2018 | 210 | 2018 |
| Studies on the TBA test for rancidity grading: II. TBA reactivity of different aldehyde classes R Marcuse, L Johansson Journal of the American Oil Chemists Society 50 (10), 387-391, 1973 | 203 | 1973 |
| The Swedish cardiopulmonary BioImage study: objectives and design G Bergström, G Berglund, A Blomberg, J Brandberg, G Engström, ... Journal of internal medicine 278 (6), 645-659, 2015 | 179 | 2015 |
